Application 209190
- Type
- ANDA
- Sponsor
- RHODES PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LIDOCAINE | LIDOCAINE | PATCH;TOPICAL | 5% | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209190-001 | LIDOCAINE | LIDOCAINE | 5% | PATCH / TOPICAL | AB | 2020-04-30 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209190-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209190-001 | LIDOCAINE | 5% | PATCH / TOPICAL | AB | 2020-04-30 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209190-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lidocaine 5% | LIDOCAINE 5% | St. Mary's Medical Park Pharmacy | 052fa8a3-0e3c-d9c2-e063-6394a90aadd7 | 2026-06-29 | Warnings, Adverse reactions | 209190 ANDA209190 |
| Lidox 5 Patch | LIDOCAINE 5% PATCH | Injecta Medcial LLC | 526b8681-098f-3410-e063-6294a90a79fb | 2026-05-22 | Warnings, Adverse reactions | 209190 ANDA209190 |
| Lidocaine 5% | LIDOCAINE 5% | YARAL Pharma Inc. | fc495fc8-15d6-27c7-e053-6394a90ab30d | 2026-03-24 | Warnings, Adverse reactions | 209190 ANDA209190 |
| Lidocan | LIDOCAINE 5% | PURETEK CORPORATION | fd8e4856-3785-4850-e053-6294a90a95b6 | 2026-01-27 | Warnings, Adverse reactions | 209190 ANDA209190 |
| Lidocaine 5% | LIDOCAINE 5% | A-S Medication Solutions | fec1e759-60e4-47d4-bd54-947f18b103dd | 2026-01-19 | Warnings, Adverse reactions | 209190 ANDA209190 |
| Lidocaine 5% Patch | LIDOCAINE 5% | Medcore LLC | 1afe428f-e223-4ef8-a6ba-968f4cfbf476 | 2026-01-12 | Warnings, Adverse reactions | 209190 ANDA209190 |
| Tridacaine III | LIDOCAINE | Trifluent Pharma LLC | 9b47102e-3b35-4aa7-a380-cd02ba9eac65 | 2025-10-13 | Warnings, Adverse reactions | 209190 ANDA209190 |
| Tridacaine XL | LIDOCAINE | Trifluent Pharma LLC | 032b37a7-8a47-4809-a330-c76314225cbd | 2025-10-13 | Warnings, Adverse reactions | 209190 ANDA209190 |
| Lidocaine 5% | LIDOCAINE 5% | REMEDYREPACK INC. | 50152ae0-aebd-4a08-a5c7-c8858e025997 | 2025-09-30 | Warnings, Adverse reactions | 209190 ANDA209190 |
| Lidocaine 5% | LIDOCAINE 5% | Asclemed USA, Inc. | 1dca5b81-72a9-4969-8552-d43091f72aab | 2025-01-10 | Warnings, Adverse reactions | 209190 ANDA209190 |
| Lidocan VI | LIDOCAINE 5% | PURETEK CORPORATION | 1b6dc518-a15b-1cf9-e063-6294a90a6357 | 2024-12-09 | Warnings, Adverse reactions | 209190 ANDA209190 |
| Lidocan VII | LIDOCAINE 5% | PURETEK CORPORATION | 1f33d51c-168c-55f2-e063-6394a90a8905 | 2024-12-09 | Warnings, Adverse reactions | 209190 ANDA209190 |
| Lidocan IV | LIDOCAINE 5% | PURETEK CORPORATION | 137f9cc1-68c0-edcc-e063-6394a90abf6a | 2024-10-25 | Warnings, Adverse reactions | 209190 ANDA209190 |
| Lidocan V | LIDOCAINE 5% | PURETEK CORPORATION | 141fe2bd-b25a-eff8-e063-6294a90a2ae8 | 2024-07-03 | Warnings, Adverse reactions | 209190 ANDA209190 |
| Lidocan III | LIDOCAINE 5% | PURETEK CORPORATION | 07a258e4-4858-43b3-e063-6394a90a5084 | 2024-07-03 | Warnings, Adverse reactions | 209190 ANDA209190 |
| Lidocaine 5% | LIDOCAINE 5% | NuCare Pharmaceuticals,Inc. | 1ac8a196-010f-a986-e063-6294a90a948f | 2024-06-13 | Warnings, Adverse reactions | 209190 ANDA209190 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 42858-118 | Lidocaine 5% | Lidocaine 5% | Rhodes Pharmaceuticals L.P. | ANDA | Current |
| 63629-2472 | Lidocaine 5% | Lidocaine 5% | Bryant Ranch Prepack | ANDA | Current |
| 63629-2472 | Lidocaine 5% | Lidocaine 5% | Bryant Ranch Prepack | ANDA | Current |
| 70518-3522 | Lidocaine 5% | Lidocaine 5% | REMEDYREPACK INC. | ANDA | Current |
| 80175-0118 | Lidocaine 5% | Lidocaine | Central Packaging | ANDA | Current |
| 80175-0118 | Lidocaine 5% | Lidocaine | Central Packaging | ANDA | Current |
| 80175-0118 | Lidocaine 5% | Lidocaine | Central Packaging | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 77884 | ORIG | 2024-08-06 |